A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors
Clinical trial NCT04420884 · COMPLETED
Trial details
- NCT number
- NCT04420884
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-22
- Primary completion
- 2026-03-30
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.